Raloxifene decreases cell viability and migratory potential in prostate cancer cells (LNCaP) with GPR30/GPER1 involvement
Salata, Giovanna Cassone, Pinho, Cristiane Figueiredo, Freitas, André T. A. G., Aquino, Ariana Musa, Justulin, Luis Antonio, Mendes, Leonardo Oliveira, Gonçalves, Bianca F., Delella, Flávia Karina, ScJournal:
Journal of Pharmacy and Pharmacology
DOI:
10.1111/jphp.13089
Date:
March, 2019
File:
PDF, 505 KB
2019
File converter
More search results
More benefits 
